Сравнение методов
Просматривайте выбранные методы рядом; строки с различиями подсвечены.
| Односторонний слепой естественный эксперимент× | Одностороннее рандомизированное контролируемое исследование× | |
|---|---|---|
| Область | Планирование эксперимента | Планирование эксперимента |
| Семейство | Process / pipeline | Process / pipeline |
| Год появления≠ | Late 20th century (formalized practice) | 1948 (formalized); single-blind variant established in mid-20th century clinical trial methodology |
| Автор метода≠ | Conceptual synthesis of natural experiment tradition (Haavelmo, 1944; Campbell & Stanley, 1963) with single-blind methodology | Bradford Hill and colleagues (MRC streptomycin trial, 1948); blinding conventions codified in CONSORT guidelines |
| Тип≠ | Quasi-experimental design with partial blinding | Experimental design — blinded randomized trial |
| Основополагающий источник≠ | Dunning, T. (2012). Natural Experiments in the Social Sciences: A Design-Based Approach. Cambridge University Press. ISBN: 978-1107698000 | Schulz, K. F., Altman, D. G., Moher, D., & CONSORT Group. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. DOI ↗ |
| Другие названия≠ | single-masked natural experiment, blinded quasi-experiment, single-blind exogenous assignment study | single-masked RCT, single-blind RCT, single-blind trial, SB-RCT |
| Связанные≠ | 2 | 5 |
| Сводка≠ | A single-blind natural experiment leverages an exogenous, researcher-uncontrolled event — such as a policy change, lottery, or natural disaster — to create treatment and comparison groups, while applying single-blind procedures so that either the participants or the outcome assessors (but not both) are unaware of group assignment. This design combines the causal leverage of natural variation with reduced measurement bias from blinding. | A single-blind randomized controlled trial (SB-RCT) is a rigorous experimental design in which participants are randomly assigned to treatment or control conditions while remaining unaware of which condition they have received. Investigators, outcome assessors, and data analysts are not blinded. By masking participants, the design eliminates placebo and nocebo response biases on the participant side, while preserving investigator flexibility to administer and monitor the intervention. |
| ScholarGateНабор данных ↗ |
|
|